Irbesartan (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Irbesartan" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

5drugs.com

399^th place

480^th place

2clincalc.com

3,912^th place

low place

2nih.gov

4^th place

13^th place

1books.google.com

3^rd place

6^th place

1web.archive.org

1^st place

1doi.org

2^nd place

4^th place

1handle.net

102^nd place

411^th place

1tga.gov.au

3,984^th place

4,575^th place

1fda.gov

447^th place

792^nd place

1canada.ca

1,712^th place

7,978^th place

books.google.com

Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. hlm. 470. ISBN 9783527607495.

canada.ca

"Nitrosamine impurities in medications: Guidance". Health Canada. 4 April 2022.

clincalc.com

"The Top 300 of 2021". ClinCalc. Diarsipkan dari versi asli tanggal 15 January 2024. Diakses tanggal 14 January 2024.
"Irbesartan - Drug Usage Statistics". ClinCalc. Diakses tanggal 14 January 2024.

doi.org

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. (September 2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes". The New England Journal of Medicine. 345 (12): 851–860. doi:10.1056/NEJMoa011303 . hdl:2445/122787 . PMID 11565517.

drugs.com

"Irbesartan Monograph for Professionals". Drugs.com. American Society of Health-System Pharmacists. Diakses tanggal 3 March 2019.
"Irbesartan Pregnancy and Breastfeeding Warnings". Drugs.com. Diakses tanggal 3 March 2019.
"Irbesartan and Hydrochlorothiazide (Professional Patient Advice)". Drugs.com. 5 June 2019. Diakses tanggal 19 March 2020.
"Irbesartan and hydrochlorothiazide Advanced Patient Information". Drugs.com. 24 December 2019. Diakses tanggal 19 March 2020.
"Irbesartan (Avapro) Use During Pregnancy". Drugs.com. 16 August 2018. Diakses tanggal 19 March 2020.

fda.gov

"Recalls of Angiotensin II Receptor Blockers (ARBs) including Valsartan, Losartan and Irbesartan". U.S. Food and Drug Administration (FDA). 10 May 2021.

handle.net

hdl.handle.net

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. (September 2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes". The New England Journal of Medicine. 345 (12): 851–860. doi:10.1056/NEJMoa011303 . hdl:2445/122787 . PMID 11565517.

nih.gov

dailymed.nlm.nih.gov

"Avalide- irbesartan and hydrochlorothiazide tablet, film coated". DailyMed. 31 July 2018. Diakses tanggal 19 March 2020.

ncbi.nlm.nih.gov

Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. (September 2001). "Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes". The New England Journal of Medicine. 345 (12): 851–860. doi:10.1056/NEJMoa011303 . hdl:2445/122787 . PMID 11565517.

tga.gov.au

"Prescription medicines: registration of new generic medicines and biosimilar medicines, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Diakses tanggal 30 March 2024.

web.archive.org

"The Top 300 of 2021". ClinCalc. Diarsipkan dari versi asli tanggal 15 January 2024. Diakses tanggal 14 January 2024.